Chaseman Global continues leadership growth with appointment of Dena Lipman.

UK, 4 March 2021 – Chaseman Global is excited to announce the appointment of strategic consultant, Dena Lipman as Non-Executive Director. Dena will be working alongside the senior leadership team to support Chaseman in further developing long-standing relationships within the healthcare industry.

As a strategic marketing consultant in pharmaceuticals, Dena develops and implements clear vision and strategy for businesses around the globe. Originally training as a clinical pharmacist and then joining ICI Pharmaceuticals she has gone on to enjoy a hugely successful career with international pharmaceutical businesses such as AstraZeneca – where she led a number of high-performing oncology and cardiovascular brands.

More recently, Dena has worked with start-ups and venture capital (Delin Ventures) to aid commercial strategy, decision making and investment proposals for new companies and products. Dena’s consultancy work has provided input to company/product strategy and implementation, messaging to bring clinical data to life, development, launch and lifecycle planning for differentiation and commercial success.

With more than 24 years’ experience in International Pharmaceuticals, Dena has an enviable track record of delivering outstanding global sales and profitability results.

Richard Connolly, CEO and Founder at Chaseman Global said: “It’s an incredibly exciting time here at Chaseman and the appointment of Dena reaffirms this. With extensive experience in the Bio and Life Sciences industry, we’re looking forward to Dena working alongside our team to support the strategic development of our healthcare divisions. Our vision is to become a leading partner for talent acquisition, retention and development in the sector and with Dena’s support I have no doubt we will achieve this.”